Gabelli Funds’s AngioDynamics ANGO Stock Holding History
Bought
Maintained
Sold
Other funds holding ANGO
TCM
Gabelli Funds's ANGO Position: Q2 2019 in Review
Gabelli Funds sold out of AngioDynamics (ANGO) in Q2 2019, closing a stake of 29,000 shares — an estimated $663K sold.
Gabelli Funds first reported a position in ANGO in Q2 2013 and held it in 24 quarters. The position peaked at $2.92M in Q4 2013. 167 funds tracked by Wall St. Rank hold ANGO as of Q2 2019.
- Gabelli Funds reported no remaining AngioDynamics position as of Q2 2019 after selling out during the quarter.
- Gabelli Funds sold 29,000 AngioDynamics shares in Q2 2019, an estimated $663K.
- Gabelli Funds first reported a position in AngioDynamics in Q2 2013 and held it in 24 quarters.
- Gabelli Funds's AngioDynamics position peaked at $2.92M in Q4 2013.
- 167 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2019.
Based on Gabelli Funds's 13F filing for Q2 2019, filed 2 Aug 2019.